Human Embryonic Stem Cells Market 2027 By Type, Application, End User and Geography | The Insight Partners

Human Embryonic Stem Cells (hESC) Market to 2027 - Global Analysis and Forecasts By Type (Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells); Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) and Geography

Report Code: TIPRE00006940 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Human embryonic stem cells (hESC) are pluripotent stem cells that are derived from the inner cell mass of a blastocyst. These cells have the ability to get differentiated into all germ layers. Researchers are conducting studies on human embryonic stem cells (hESC) in order to discover the treatment for conditions like diabetes and heart disease. In recent years human embryonic stem cells (hESC) is gaining attention as it has the potential to produce specialized cells and replace the damaged tissue in patients, who are suffering from various diseases.

MARKET DYNAMICS

The human embryonic stem cells (hESC) market is anticipated to grow in the forecast, owing to the factors such as constant technological advancement in stem cell therapy, increasing demand for regenerative medicines, and growing research and development activities in toxicology testing. Furthermore, a maturing and strongly diversified product pipeline is likely to pose growth opportunities for the human embryonic stem cells (hESC) market to grow.

MARKET SCOPE

The "Global Human embryonic stem cells (hESC) market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of human embryonic stem cells (hESC) market with detailed market segmentation by type, application, end user and geography. The global human embryonic stem cells (hESC) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading human embryonic stem cells (hESC) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global human embryonic stem cells (hESC) market is segmented on the basis of type, application, and end user. Based on type, the market is segmented into totipotent stem cells, pluripotent stem cells, and unipotent stem cells. Based on application the market is segmented into regenerative medicine, stem cell biology research, tissue engineering and toxicology testing. The end user segment is segmented into pharmaceutical and biotechnology companies, academic and research institutes and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global human embryonic stem cells (hESC) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human embryonic stem cells (hESC) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting human embryonic stem cells (hESC) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human embryonic stem cells (hESC) market in these regions.

MARKET PLAYERS

The reports cover key developments in the human embryonic stem cells (hESC) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from human embryonic stem cells (hESC) market are anticipated to lucrative growth opportunities in the future with the rising demand for human embryonic stem cells (hESC) market in the global market. Below mentioned is the list of few companies engaged in the human embryonic stem cells (hESC) market.

The report also includes the profiles of human embryonic stem cells (hESC) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Thermo Fisher Scientific, Inc.
- CellGenix GmbH
- ESI BIO
- PromoCell GmbH
- Lonza
- Kite Pharma
- LifeCell
- International Stem Cell Corporation.
- R and D Systems, Inc.
- Takara Bio Inc

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Embryonic Stem Cells (hESC) Market - By Type
1.3.2 Human Embryonic Stem Cells (hESC) Market - By Application
1.3.3 Human Embryonic Stem Cells (hESC) Market - By End User
1.3.4 Human Embryonic Stem Cells (hESC) Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN EMBRYONIC STEM CELLS (HESC) - GLOBAL MARKET OVERVIEW
6.2. HUMAN EMBRYONIC STEM CELLS (HESC) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TOTIPOTENT STEM CELLS
7.3.1. Overview
7.3.2. Totipotent Stem Cells Market Forecast and Analysis
7.4. PLURIPOTENT STEM CELLS
7.4.1. Overview
7.4.2. Pluripotent Stem Cells Market Forecast and Analysis
7.5. UNIPOTENT STEM CELLS
7.5.1. Overview
7.5.2. Unipotent Stem Cells Market Forecast and Analysis
8. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. REGENERATIVE MEDICINE
8.3.1. Overview
8.3.2. Regenerative Medicine Market Forecast and Analysis
8.4. STEM CELL BIOLOGY RESEARCH
8.4.1. Overview
8.4.2. Stem Cell Biology Research Market Forecast and Analysis
8.5. TISSUE ENGINEERING
8.5.1. Overview
8.5.2. Tissue Engineering Market Forecast and Analysis
8.6. TOXICOLOGY TESTING
8.6.1. Overview
8.6.2. Toxicology Testing Market Forecast and Analysis
9. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. ACADEMIC AND RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic and Research Institutes Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Human Embryonic Stem Cells (hESC) Market Overview
10.1.2 North America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis
10.1.3 North America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Type
10.1.4 North America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Application
10.1.5 North America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By End User
10.1.6 North America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Human Embryonic Stem Cells (hESC) Market
10.1.6.1.1 United States Human Embryonic Stem Cells (hESC) Market by Type
10.1.6.1.2 United States Human Embryonic Stem Cells (hESC) Market by Application
10.1.6.1.3 United States Human Embryonic Stem Cells (hESC) Market by End User
10.1.6.2 Canada Human Embryonic Stem Cells (hESC) Market
10.1.6.2.1 Canada Human Embryonic Stem Cells (hESC) Market by Type
10.1.6.2.2 Canada Human Embryonic Stem Cells (hESC) Market by Application
10.1.6.2.3 Canada Human Embryonic Stem Cells (hESC) Market by End User
10.1.6.3 Mexico Human Embryonic Stem Cells (hESC) Market
10.1.6.3.1 Mexico Human Embryonic Stem Cells (hESC) Market by Type
10.1.6.3.2 Mexico Human Embryonic Stem Cells (hESC) Market by Application
10.1.6.3.3 Mexico Human Embryonic Stem Cells (hESC) Market by End User
10.2. EUROPE
10.2.1 Europe Human Embryonic Stem Cells (hESC) Market Overview
10.2.2 Europe Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis
10.2.3 Europe Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Type
10.2.4 Europe Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Application
10.2.5 Europe Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By End User
10.2.6 Europe Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Human Embryonic Stem Cells (hESC) Market
10.2.6.1.1 Germany Human Embryonic Stem Cells (hESC) Market by Type
10.2.6.1.2 Germany Human Embryonic Stem Cells (hESC) Market by Application
10.2.6.1.3 Germany Human Embryonic Stem Cells (hESC) Market by End User
10.2.6.2 France Human Embryonic Stem Cells (hESC) Market
10.2.6.2.1 France Human Embryonic Stem Cells (hESC) Market by Type
10.2.6.2.2 France Human Embryonic Stem Cells (hESC) Market by Application
10.2.6.2.3 France Human Embryonic Stem Cells (hESC) Market by End User
10.2.6.3 Italy Human Embryonic Stem Cells (hESC) Market
10.2.6.3.1 Italy Human Embryonic Stem Cells (hESC) Market by Type
10.2.6.3.2 Italy Human Embryonic Stem Cells (hESC) Market by Application
10.2.6.3.3 Italy Human Embryonic Stem Cells (hESC) Market by End User
10.2.6.4 Spain Human Embryonic Stem Cells (hESC) Market
10.2.6.4.1 Spain Human Embryonic Stem Cells (hESC) Market by Type
10.2.6.4.2 Spain Human Embryonic Stem Cells (hESC) Market by Application
10.2.6.4.3 Spain Human Embryonic Stem Cells (hESC) Market by End User
10.2.6.5 United Kingdom Human Embryonic Stem Cells (hESC) Market
10.2.6.5.1 United Kingdom Human Embryonic Stem Cells (hESC) Market by Type
10.2.6.5.2 United Kingdom Human Embryonic Stem Cells (hESC) Market by Application
10.2.6.5.3 United Kingdom Human Embryonic Stem Cells (hESC) Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Overview
10.3.2 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis
10.3.3 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Human Embryonic Stem Cells (hESC) Market
10.3.6.1.1 Australia Human Embryonic Stem Cells (hESC) Market by Type
10.3.6.1.2 Australia Human Embryonic Stem Cells (hESC) Market by Application
10.3.6.1.3 Australia Human Embryonic Stem Cells (hESC) Market by End User
10.3.6.2 China Human Embryonic Stem Cells (hESC) Market
10.3.6.2.1 China Human Embryonic Stem Cells (hESC) Market by Type
10.3.6.2.2 China Human Embryonic Stem Cells (hESC) Market by Application
10.3.6.2.3 China Human Embryonic Stem Cells (hESC) Market by End User
10.3.6.3 India Human Embryonic Stem Cells (hESC) Market
10.3.6.3.1 India Human Embryonic Stem Cells (hESC) Market by Type
10.3.6.3.2 India Human Embryonic Stem Cells (hESC) Market by Application
10.3.6.3.3 India Human Embryonic Stem Cells (hESC) Market by End User
10.3.6.4 Japan Human Embryonic Stem Cells (hESC) Market
10.3.6.4.1 Japan Human Embryonic Stem Cells (hESC) Market by Type
10.3.6.4.2 Japan Human Embryonic Stem Cells (hESC) Market by Application
10.3.6.4.3 Japan Human Embryonic Stem Cells (hESC) Market by End User
10.3.6.5 South Korea Human Embryonic Stem Cells (hESC) Market
10.3.6.5.1 South Korea Human Embryonic Stem Cells (hESC) Market by Type
10.3.6.5.2 South Korea Human Embryonic Stem Cells (hESC) Market by Application
10.3.6.5.3 South Korea Human Embryonic Stem Cells (hESC) Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Overview
10.4.2 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis
10.4.3 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Human Embryonic Stem Cells (hESC) Market
10.4.6.1.1 South Africa Human Embryonic Stem Cells (hESC) Market by Type
10.4.6.1.2 South Africa Human Embryonic Stem Cells (hESC) Market by Application
10.4.6.1.3 South Africa Human Embryonic Stem Cells (hESC) Market by End User
10.4.6.2 Saudi Arabia Human Embryonic Stem Cells (hESC) Market
10.4.6.2.1 Saudi Arabia Human Embryonic Stem Cells (hESC) Market by Type
10.4.6.2.2 Saudi Arabia Human Embryonic Stem Cells (hESC) Market by Application
10.4.6.2.3 Saudi Arabia Human Embryonic Stem Cells (hESC) Market by End User
10.4.6.3 U.A.E Human Embryonic Stem Cells (hESC) Market
10.4.6.3.1 U.A.E Human Embryonic Stem Cells (hESC) Market by Type
10.4.6.3.2 U.A.E Human Embryonic Stem Cells (hESC) Market by Application
10.4.6.3.3 U.A.E Human Embryonic Stem Cells (hESC) Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Human Embryonic Stem Cells (hESC) Market Overview
10.5.2 South and Central America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis
10.5.3 South and Central America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Type
10.5.4 South and Central America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Application
10.5.5 South and Central America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By End User
10.5.6 South and Central America Human Embryonic Stem Cells (hESC) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Human Embryonic Stem Cells (hESC) Market
10.5.6.1.1 Brazil Human Embryonic Stem Cells (hESC) Market by Type
10.5.6.1.2 Brazil Human Embryonic Stem Cells (hESC) Market by Application
10.5.6.1.3 Brazil Human Embryonic Stem Cells (hESC) Market by End User
10.5.6.2 Argentina Human Embryonic Stem Cells (hESC) Market
10.5.6.2.1 Argentina Human Embryonic Stem Cells (hESC) Market by Type
10.5.6.2.2 Argentina Human Embryonic Stem Cells (hESC) Market by Application
10.5.6.2.3 Argentina Human Embryonic Stem Cells (hESC) Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMAN EMBRYONIC STEM CELLS (HESC) MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELLGENIX GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ESI BIO
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PROMOCELL GMBH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LONZA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. KITE PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIFECELL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INTERNATIONAL STEM CELL CORPORATION.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. R AND D SYSTEMS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TAKARA BIO INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific, Inc.
2. CellGenix GmbH
3. ESI BIO
4. PromoCell GmbH
5. Lonza
6. Kite Pharma
7. LifeCell
8. International Stem Cell Corporation.
9. R and D Systems, Inc.
10. Takara Bio Inc